Foresite Capital Management Iv, LLC Keros Therapeutics, Inc. Transaction History

Foresite Capital Management Iv, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$42.4 - $70.11 $58.6 Million - $96.9 Million	-1,382,641 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$54.0 - $75.28 $1.62 Million - $2.26 Million	-30,064 Reduced 2.13%	1,382,641 $85.1 Million
Q3 2020 Nov 13, 2020	SELL	$27.04 - $62.21 $415,496 - $955,918	-15,366 Reduced 1.08%	1,412,705 $54.5 Million
Q2 2020 Aug 13, 2020	BUY	$20.08 - $40.39 $28.7 Million - $57.7 Million	1,428,071 New	1,428,071 $53.6 Million

156

27.5M

28.7K

1.8K

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $1.54B
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

Get notified when there are updates to the investment portfolio of Foresite Capital Management Iv, LLC, based on Form 13F filings with the SEC.

Stay updated on Foresite Capital Management Iv, LLC with notifications on news.